Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 67INDUSTRY 52NIH 10OTHER_GOV 2NETWORK 2UNKNOWN 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Breast Neoplasms 3Urinary Bladder Neoplasms 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Urethral Neoplasms 1Sarcoma, Synovial 1Sarcoma 1Prostatic Neoplasms 1Kidney Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Carboplatin 34Paclitaxel 29Radiotherapy 23Cisplatin 23Docetaxel 18Pemetrexed 14Gemcitabine 14Radiosurgery 10Bevacizumab 9Magnetic Resonance Spectroscopy 7Etoposide 7Ramucirumab 6Erlotinib Hydrochloride 6Cetuximab 6Specimen Handling 5Gene Expression Profiling 5durvalumab 4cediranib 4Vinorelbine 4Polymerase Chain Reaction 4Amplified Fragment Length Polymorphism Analysis 4pembrolizumab 3cemiplimab 3Watchful Waiting 3Taxes 3Surgical Procedures, Operative 3Radiotherapy, Conformal 3Psychiatric Rehabilitation 3Neoadjuvant Therapy 3Fluorodeoxyglucose F18 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Carcinoma, Non-Small-Cell Lung × Gefitinib × Clear all
NCT00091156 2012-07-16

Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Terminated
598 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00103051 2012-07-16

Gemcitabine, Cisplatin, and Gefitinib in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡